{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05256290",
            "orgStudyIdInfo": {
                "id": "BDTX-1535-101"
            },
            "organization": {
                "fullName": "Black Diamond Therapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Phase 1/2 Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations",
            "officialTitle": "A Phase 1/2 Study to Assess BDTX-1535, an Oral EGFR Inhibitor, in Patients With Glioblastoma or Non-Small Cell Lung Cancer",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "phase-study-of-bdtx-in-patients-with-glioblastoma-or-non-small-cell-lung-cancer-with-egfr-mutations"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-03-31",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-07",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-02-15",
            "studyFirstSubmitQcDate": "2022-02-24",
            "studyFirstPostDateStruct": {
                "date": "2022-02-25",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-29",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-30",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Black Diamond Therapeutics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "BDTX-1535-101 is an open-label, Phase 1 dose escalation and Phase 2 multiple cohort study designed to evaluate the safety, pharmacokinetics (PK), optimal dosage, central nervous system (CNS) activity, and antitumor activity of BDTX-1535. The study population comprises adults with either advanced/metastatic non-small cell lung cancer (NSCLC) with non-classical or acquired epidermal growth factor receptor (EGFR) resistance (EGFR C797S) mutations with or without CNS disease (in Phase 1 and Phase 2), or glioblastoma (GBM) expressing EGFR alterations (Phase 1 only). All patients will self-administer BDTX-1535 monotherapy by mouth in 21-day cycles.\n\nPhase 1 enrollment is now complete. Phase 2 is currently enrolling."
        },
        "conditionsModule": {
            "conditions": [
                "Non-Small Cell Lung Cancer",
                "Advanced Non-Small Cell Squamous Lung Cancer",
                "Metastatic Lung Non-Small Cell Carcinoma",
                "Metastatic Lung Cancer",
                "NSCLC",
                "Advanced Lung Carcinoma",
                "Epidermal Growth Factor Receptor C797S",
                "Epidermal Growth Factor Receptor G719X",
                "EGF-R Positive Non-Small Cell Lung Cancer",
                "EGFR-TKI Resistant Mutation"
            ],
            "keywords": [
                "EGFR alterations",
                "EGFR L858R",
                "EGFR Exon 19 del",
                "EGFR inhibitor",
                "intrinsic resistance NSCLC EGFR",
                "acquired resistance NSCLC EGFR",
                "intracranial disease",
                "brain metastases",
                "central nervous system metastases",
                "CNS metastases",
                "uncommon NSCLC EGFR mutations",
                "C797S acquired resistance EGFR mutation",
                "non-classical NSCLC EGFR mutations",
                "classical NSCLC EGFR mutations",
                "EGFR PACC NSCLC mutations",
                "EGFR E709A/G/K/Q/V",
                "EGFR E709_T710delinsD/T",
                "EGFR G719A/C/D/R/S",
                "EGFR G724S",
                "EGFR L718Q/V",
                "EGFR L747S/P, L747_A750delinsP, L747_P753delinsS",
                "Second-site EGFR mutation"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 200,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Phase 1 Dose Escalation - Monotherapy (Recruitment Closed)",
                    "type": "EXPERIMENTAL",
                    "description": "* Advanced/metastatic NSCLC with acquired resistance EGFR mutation (eg, C797S), following a 3rd generation EGFR inhibitor in the 1st line setting (in the absence of concurrent T790M).\n* Advanced/metastatic NSCLC with non-classical EGFR mutation (eg, G719X) following standard-of-care therapy with an EGFR inhibitor\n* Recurrent GBM with confirmed EGFR alterations (including amplification, mutation, and/or variant)",
                    "interventionNames": [
                        "Drug: BDTX-1535 monotherapy"
                    ]
                },
                {
                    "label": "Phase 2 Cohort 1: NSCLC EGFR Non-Classical Driver Mutations",
                    "type": "EXPERIMENTAL",
                    "description": "Advanced/metastatic NSCLC with a non-classical driver EGFR mutation following up to 2 lines of therapy with only 1 prior EGFR targeted regimen (third-generation preferred; other approved EGFR inhibitors acceptable)",
                    "interventionNames": [
                        "Drug: BDTX-1535 monotherapy"
                    ]
                },
                {
                    "label": "Phase 2 Cohort 2: NSCLC EGFR Acquired Resistance (C797S) Mutation",
                    "type": "EXPERIMENTAL",
                    "description": "Advanced/metastatic NSCLC with the acquired resistance C797S EGFR mutation following up to 2 lines of therapy, including only 1 EGFR targeted regimen, which must be a third generation EGFR TKI (eg, osimertinib)",
                    "interventionNames": [
                        "Drug: BDTX-1535 monotherapy"
                    ]
                },
                {
                    "label": "Phase 2 Cohort 3: Treatment Naive NSCLC EGFR Non-Classical Driver Mutations",
                    "type": "EXPERIMENTAL",
                    "description": "Treatment-na\u00efve (first-line) advanced/metastatic NSCLC with a non-classical driver EGFR mutation (1 cycle of chemotherapy or immune checkpoint inhibitor are permitted). Patients with co-occurring L858R mutations and a non-classical mutation are eligible for inclusion.",
                    "interventionNames": [
                        "Drug: BDTX-1535 monotherapy"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "BDTX-1535 monotherapy",
                    "description": "BDTX-1535 is a 4th generation irreversible brain penetrant EGFR MasterKey inhibitor, which targets a family of oncogenic EGFR classical and non-classical driver and resistance mutations in NSCLC.",
                    "armGroupLabels": [
                        "Phase 1 Dose Escalation - Monotherapy (Recruitment Closed)",
                        "Phase 2 Cohort 1: NSCLC EGFR Non-Classical Driver Mutations",
                        "Phase 2 Cohort 2: NSCLC EGFR Acquired Resistance (C797S) Mutation",
                        "Phase 2 Cohort 3: Treatment Naive NSCLC EGFR Non-Classical Driver Mutations"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Phase 1 Dose Escalation: To determine the maximum tolerated dose (MTD), if one exists, and the preliminary recommended Phase 2 dose(s) (RP2D[s]) of BDTX-1535",
                    "description": "Dose-limiting toxicities (DLTs) in Cycle 1",
                    "timeFrame": "The first treatment 21-day cycle (Cycle 1)"
                },
                {
                    "measure": "Phase 2: To assess antitumor efficacy of BDTX-1535",
                    "description": "Objective response rate (ORR) as assessed by Investigator using RECIST version 1.1",
                    "timeFrame": "Day 1 every 2 cycles starting on Cycle 3 Day 1 to study completion, approximately 1 year (each cycle is 21 days)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Phase 1 and Phase 2: Incidence and severity of treatment-emergent adverse events (TEAEs)",
                    "timeFrame": "Through study completion, approximately 1 year"
                },
                {
                    "measure": "Phase 1 and Phase 2: To characterize the plasma concentration of BDTX-1535 following single and multiple dosing",
                    "timeFrame": "Cycle 1 Days 1, 2, 15, and 16, Cycles 2 to 5 Day 1, and Day 1 of every other cycle thereafter to study completion, approximately 1 year (each cycle is 21 days)"
                },
                {
                    "measure": "Phase 1: To assess the preliminary antitumor activity of BDTX-1535 by objective response as assessed by RECIST version 1.1 (for patients with NSCLC) or Response Assessment in Neuro-oncology (RANO) (for patients with GBM)",
                    "timeFrame": "Day 1 every 2 cycles starting on Cycle 3 Day 1 to study completion, approximately 1 year (each cycle is 21 days)"
                },
                {
                    "measure": "Phase 1: To assess the effect of tablet formulation on the plasma concentration of BDTX-1535",
                    "timeFrame": "Two timepoints during the first cycle: Cycle 0 (7 days prior to Cycle 1 Day 1) and Cycle 1 Day 1 only (each cycle is 21 days)"
                },
                {
                    "measure": "Phase 1: To assess the effect of food on the plasma concentration of BDTX-1535",
                    "timeFrame": "Two timepoints during the first cycle: Cycle 0 (7 days prior to Cycle 1 Day 1) and Cycle 1 Day 1 only (each cycle is 21 days)"
                },
                {
                    "measure": "Phase 2: To assess duration of tumor response by RECIST version 1.1",
                    "timeFrame": "Day 1 every 2 cycles starting at Cycle 3 Day 1 to study completion, approximately 1 year (each cycle is 21 days)"
                },
                {
                    "measure": "Phase 2: To assess progression free survival by RECIST version 1.1",
                    "timeFrame": "Day 1 every 2 cycles starting at Cycle 3 Day 1 to study completion, approximately 1 year (each cycle is 21 days)"
                },
                {
                    "measure": "Phase 2: To evaluate CNS ORR by RANO for brain metastases criteria (RANO-BM)",
                    "timeFrame": "Day 1 every 2 cycles starting on Cycle 3 Day 1 to study completion, approximately 1 year (each cycle is 21 days)"
                },
                {
                    "measure": "Phase 2: To assess NSCLC disease-related symptoms and change of symptoms with BDTX-1535 treatment",
                    "description": "Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ); Verbal rating scale used (for example: Never/Rarely/Sometimes/Often/Always)",
                    "timeFrame": "At select timepoints: Cycle 1 Day, Cycle 3 Day 1, Cycle 5 Day 1, Cycle 7 Day 1, Cycle 9 Day 1, and at study completion, approximately 1 year (each cycle is 21 days)"
                },
                {
                    "measure": "Phase 2: To assess treatment related side effects with BDTX-1535",
                    "description": "National Cancer Institute Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (NCI-PRO-CTCAE) Survey: Rating scale used (for example never/rarely/occasionally/frequently/almost constantly)",
                    "timeFrame": "At select timepoints: Cycle 1 Day, Cycle 3 Day 1, Cycle 5 Day 1, Cycle 7 Day 1, Cycle 9 Day 1, and at study completion, approximately 1 year (each cycle is 21 days)"
                },
                {
                    "measure": "Phase 2: To determine the optimal dosage of BDTX-1535 (100 mg or 200 mg daily dose)",
                    "timeFrame": "At least the first treatment 21-day cycle (Cycle 1) for select patients enrolled into the Phase 2"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Phase 2 Eligibility:\n\nKey Inclusion Criteria Required for locally advanced or metastatic NSCLC:\n\n* Measurable disease by RECIST 1.1 criteria.\n* Adequate bone marrow or organ function.\n* Life expectancy of \u2265 3 months.\n* Sufficient performance status.\n* Confirmed NSCLC, without small cell lung cancer transformation with or without brain metastases.\n* Disease progression following or intolerance of standard of care (excluding patients in the treatment-na\u00efve non-classical driver cohort):\n\n  * Cohort 1 (Non-Classical driver cohort): Advanced/metastatic NSCLC with a non-classical driver EGFR mutation (eg, G719X) following up to 2 lines of therapy with only 1 prior EGFR TKI regimen (third-generation preferred; other approved EGFR TKI acceptable).\n  * Cohort 2 (Acquired resistance C797S cohort): Advanced/metastatic NSCLC with the acquired resistance C797S EGFR mutation following up to 2 lines of therapy, including only one EGFR TKI, which must be a third generation EGFR TKI (eg, osimertinib).\n  * Cohort 3 (First-line non-classical driver cohort): Treatment-na\u00efve advanced/metastatic NSCLC with a non-classical driver EGFR mutation (1 cycle of chemotherapy or immune checkpoint inhibitor are permitted). Patients with co-occurring L858R mutations and a non-classical mutation are eligible for inclusion.\n* Identification of one (or more) of the following EGFR mutations by Next Generation Sequencing (NGS) as determined by a local assay performed in a validated laboratory in the absence of other known resistance mutations (eg, T790M, MET):\n\n  * Non-classical driver EGFR mutations (eg, L861R, S768I, G719X).\n  * EGFR acquired resistance mutation (eg, C797S) to a 3rd generation EGFR TKI.\n  * For Phase 2, dose expansion, patients in Cohort 1 who received 3rd generation EGFR TKI (eg, osimertinib), the NGS report within 6 months prior to the start of Screening is acceptable. For patients in Cohort 2, the NGS report must be from the last disease progression on the immediate prior therapy. For patients in Cohort 3, the NGS report must be at the time of diagnosis.\n\nKey Exclusion Criteria:\n\n* Known resistant mutations in tumor tissue or by liquid biopsy (eg, T790M, MET).\n* Received more than 1 EGFR TKI therapy (ie, erlotinib or gefitinib) for the treatment of metastatic or recurrent EGFR NSCLC.\n* Any history of interstitial lung disease related to EGFR TKI use.\n* Symptomatic or radiographic leptomeningeal disease.\n* Symptomatic brain metastases or spinal cord compression requiring urgent clinical intervention.\n* Unresolved toxicity from prior therapy.\n* Significant cardiovascular disease.\n* Major surgery within 4 weeks of study entry or planned during study.\n* Ongoing or recent anticancer therapy or radiation therapy.\n* Evidence of malignancy (other than study-specific malignancies) requiring active therapy within the next 2 years.\n* Active hepatitis B or C infection and/or known human immunodeficiency virus (HIV) carrier.\n* Poorly controlled gastrointestinal disorders.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "BDTX Clinical Trial Navigation Service",
                    "role": "CONTACT",
                    "phone": "(866) 955-4397",
                    "email": "blackdiamondtx@careboxhealth.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Black Diamond Therapeutics",
                    "affiliation": "Black Diamond Therapeutics",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Alabama",
                    "status": "RECRUITING",
                    "city": "Birmingham",
                    "state": "Alabama",
                    "zip": "35294",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Anna Wilbanks",
                            "role": "CONTACT",
                            "phone": "205-934-6454",
                            "email": "annaburton@uabmc.edu"
                        },
                        {
                            "name": "Ashley Strickland Brewer",
                            "role": "CONTACT",
                            "phone": "(205) 527-1935",
                            "email": "alstrickland@uabmc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.52066,
                        "lon": -86.80249
                    }
                },
                {
                    "facility": "Beverly Hills Cancer Center",
                    "status": "RECRUITING",
                    "city": "Beverly Hills",
                    "state": "California",
                    "zip": "90211",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ali Muhammad, MD",
                            "role": "CONTACT",
                            "phone": "310-432-8934",
                            "email": "AMuhammad@BHCancerCenter.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.07362,
                        "lon": -118.40036
                    }
                },
                {
                    "facility": "City of Hope Comprehensive Cancer Center (Duarte Campus)",
                    "status": "RECRUITING",
                    "city": "Duarte",
                    "state": "California",
                    "zip": "91010",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Danny Nguyen, MD",
                            "role": "CONTACT",
                            "phone": "877-467-3411",
                            "email": "dannynguyen@coh.org"
                        },
                        {
                            "role": "CONTACT",
                            "phone": "626-218-1133"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.13945,
                        "lon": -117.97729
                    }
                },
                {
                    "facility": "City of Hope Huntington Beach",
                    "status": "RECRUITING",
                    "city": "Huntington Beach",
                    "state": "California",
                    "zip": "92648",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Danny Nguyen, MD",
                            "role": "CONTACT",
                            "phone": "877-467-3411",
                            "email": "dannynguyen@coh.org"
                        },
                        {
                            "role": "CONTACT",
                            "phone": "626-218-1133"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.6603,
                        "lon": -117.99923
                    }
                },
                {
                    "facility": "City of Hope Orange County Lennar Foundation Cancer Center",
                    "status": "RECRUITING",
                    "city": "Irvine",
                    "state": "California",
                    "zip": "92618",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Danny Nguyen, MD",
                            "role": "CONTACT",
                            "phone": "877-467-3411",
                            "email": "dannynguyen@coh.org"
                        },
                        {
                            "role": "CONTACT",
                            "phone": "626-218-1133"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.66946,
                        "lon": -117.82311
                    }
                },
                {
                    "facility": "Valkyrie Clinical Trials",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90067",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "David Berz, MD",
                            "role": "CONTACT",
                            "email": "david.berz@valkyrieclinicaltrials.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "HealthOne Denver",
                    "status": "RECRUITING",
                    "city": "Denver",
                    "state": "Colorado",
                    "zip": "80218",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jason Henry, MD",
                            "role": "CONTACT",
                            "phone": "720-754-2610",
                            "email": "CANN.DDUDenverGeneral@sarahcannon.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.73915,
                        "lon": -104.9847
                    }
                },
                {
                    "facility": "Johns Hopkins Bayview Medical Center",
                    "status": "RECRUITING",
                    "city": "Washington",
                    "state": "District of Columbia",
                    "zip": "20016",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Judith Lawrence",
                            "role": "CONTACT",
                            "phone": "202-660-6500",
                            "email": "sibleyoncresreferral@live.johnshopkins.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.89511,
                        "lon": -77.03637
                    }
                },
                {
                    "facility": "Sibley Memorial Hospital Johns Hopkins Medicine",
                    "status": "RECRUITING",
                    "city": "Washington",
                    "state": "District of Columbia",
                    "zip": "20016",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Judith Lawrence",
                            "role": "CONTACT",
                            "phone": "202-660-6500",
                            "email": "sibleyoncresreferral@live.johnshopkins.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.89511,
                        "lon": -77.03637
                    }
                },
                {
                    "facility": "Baptist Health Miami",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33176",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Xiaoou Pan",
                            "role": "CONTACT",
                            "phone": "785-594-7856",
                            "email": "Xiaoou.pan@baptisthealth.net"
                        },
                        {
                            "name": "Jorge Valdes",
                            "role": "CONTACT",
                            "phone": "786-527-8658",
                            "email": "jorgeLV@baptisthealth.net"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Robert H. Lurie Comprehensive Cancer Center at Northwestern University",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60611",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "clinicaltrials@northwestern.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "University of Kansas Cancer Center",
                    "status": "RECRUITING",
                    "city": "Kansas City",
                    "state": "Kansas",
                    "zip": "66160",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "KUCC Navigation",
                            "role": "CONTACT",
                            "phone": "913-588-3671",
                            "email": "kucc_navigation@kumc.edu"
                        },
                        {
                            "name": "Jan Ward",
                            "role": "CONTACT",
                            "email": "jward3@kumc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.11417,
                        "lon": -94.62746
                    }
                },
                {
                    "facility": "Dana-Farber Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02115",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dawn Bissessar",
                            "role": "CONTACT",
                            "phone": "617-632-5119",
                            "email": "dawn_bissessar@dfci.harvard.edu"
                        },
                        {
                            "name": "Samantha Claussen",
                            "role": "CONTACT",
                            "phone": "617- 632-6217",
                            "email": "Samantha_claussen@dfci.harvard.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Siteman Cancer Center",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63110",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "314-747-7222",
                            "email": "Patient_Care_Coordination_Center@bjc.org"
                        },
                        {
                            "role": "CONTACT",
                            "phone": "800-600-3606"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "Montefiore Medical Center",
                    "status": "RECRUITING",
                    "city": "Bronx",
                    "state": "New York",
                    "zip": "10461",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Balazs Halmos, MD",
                            "role": "CONTACT",
                            "phone": "718-405-8404",
                            "email": "bahalmos@montefiore.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.84985,
                        "lon": -73.86641
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10021",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Helena Yu, MD",
                            "role": "CONTACT",
                            "phone": "646-608-3912",
                            "email": "yuh@mskcc.org"
                        },
                        {
                            "name": "Khadeja Moses",
                            "role": "CONTACT",
                            "phone": "646-608-3912",
                            "email": "mosesk1@mskcc.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Cleveland Clinic",
                    "status": "RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44195",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "James Stevenson, MD",
                            "role": "CONTACT",
                            "phone": "216-636-6888",
                            "email": "stevenj5@ccf.org"
                        },
                        {
                            "name": "Nathan Pennell, MD, PhD",
                            "role": "CONTACT",
                            "phone": "216-445-9282",
                            "email": "penneln@ccf.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "Thomas Jefferson University/Sidney Kimmel Cancer Center",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19107",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Aliya Rogers",
                            "role": "CONTACT",
                            "email": "AskPhase1@jefferson.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Prisma Health",
                    "status": "RECRUITING",
                    "city": "Greenville",
                    "state": "South Carolina",
                    "zip": "29605",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lisa Johnson",
                            "role": "CONTACT",
                            "phone": "864-455-3735",
                            "email": "Lisa.Johnson@prismahealth.org"
                        },
                        {
                            "name": "Fiona Davidson",
                            "role": "CONTACT",
                            "phone": "864-455-3737",
                            "email": "Fiona.Davidson@prismahealth.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.85262,
                        "lon": -82.39401
                    }
                },
                {
                    "facility": "Tennessee Oncology",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37203",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Melissa Johnson, MD",
                            "role": "CONTACT",
                            "phone": "615-320-5090",
                            "email": "melissa.johnson@scri.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "Mary Crowley Cancer Research",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75230",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Minal Barve, MD",
                            "role": "CONTACT",
                            "phone": "972-566-3000",
                            "email": "MBarve@marycrowley.org"
                        },
                        {
                            "role": "CONTACT",
                            "phone": "214-658-1962",
                            "email": "referral@marycrowley.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Texas Oncology - Baylor Charles A. Sammons Cancer Center",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75246",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Christine Terraciano",
                            "role": "CONTACT",
                            "phone": "214-370-1942",
                            "email": "Christine.Terraciano@usoncology.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Next Ocology",
                    "status": "RECRUITING",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22031",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Blake Patterson",
                            "role": "CONTACT",
                            "email": "bpatterson@nextoncology.com"
                        },
                        {
                            "name": "Rebecca Fisher",
                            "role": "CONTACT",
                            "email": "rfisher@nextoncology.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                },
                {
                    "facility": "Fred Hutchinson Cancer Center/University of Washington",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98109",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sam Woodman",
                            "role": "CONTACT",
                            "phone": "206-606-6346",
                            "email": "swoodman@fredhutch.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30",
            "removedCountries": [
                "Korea, Republic of"
            ]
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000008175",
                    "term": "Lung Neoplasms"
                },
                {
                    "id": "D000002289",
                    "term": "Carcinoma, Non-Small-Cell Lung"
                },
                {
                    "id": "D000005909",
                    "term": "Glioblastoma"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000012142",
                    "term": "Respiratory Tract Neoplasms"
                },
                {
                    "id": "D000013899",
                    "term": "Thoracic Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000002283",
                    "term": "Carcinoma, Bronchogenic"
                },
                {
                    "id": "D000001984",
                    "term": "Bronchial Neoplasms"
                },
                {
                    "id": "D000001254",
                    "term": "Astrocytoma"
                },
                {
                    "id": "D000005910",
                    "term": "Glioma"
                },
                {
                    "id": "D000018302",
                    "term": "Neoplasms, Neuroepithelial"
                },
                {
                    "id": "D000017599",
                    "term": "Neuroectodermal Tumors"
                },
                {
                    "id": "D000009373",
                    "term": "Neoplasms, Germ Cell and Embryonal"
                },
                {
                    "id": "D000009380",
                    "term": "Neoplasms, Nerve Tissue"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5546",
                    "name": "Carcinoma, Non-Small-Cell Lung",
                    "asFound": "Non-small Cell Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "asFound": "Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "asFound": "Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12307",
                    "name": "Neoplasm Metastasis",
                    "relevance": "LOW"
                },
                {
                    "id": "M9019",
                    "name": "Glioblastoma",
                    "asFound": "Glioblastoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M14979",
                    "name": "Respiratory Tract Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16658",
                    "name": "Thoracic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5540",
                    "name": "Carcinoma, Bronchogenic",
                    "relevance": "LOW"
                },
                {
                    "id": "M5260",
                    "name": "Bronchial Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M4561",
                    "name": "Astrocytoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M9020",
                    "name": "Glioma",
                    "relevance": "LOW"
                },
                {
                    "id": "M20446",
                    "name": "Neoplasms, Neuroepithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M19845",
                    "name": "Neuroectodermal Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20388",
                    "name": "Neuroectodermal Tumors, Primitive",
                    "relevance": "LOW"
                },
                {
                    "id": "M12318",
                    "name": "Neoplasms, Germ Cell and Embryonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M12325",
                    "name": "Neoplasms, Nerve Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "T2518",
                    "name": "Glioblastoma",
                    "asFound": "Glioblastoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2519",
                    "name": "Glioma",
                    "relevance": "LOW"
                },
                {
                    "id": "T4092",
                    "name": "Neuroepithelioma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M145673",
                    "name": "Osimertinib",
                    "relevance": "LOW"
                },
                {
                    "id": "M2342",
                    "name": "Immune Checkpoint Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}